Aldeyra Therapeutics Inc. (ALDX)
NASDAQ · Healthcare
Aldeyra Therapeutics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -35.3M | -60.1M | -42.8M | -62.7M | -56.2M | -34.7M |
| EBITDA | -31.7M | -53.7M | -35.2M | -60.1M | -55.8M | -34.3M |
| Net Income | -33.8M | -55.9M | -37.5M | -62.0M | -57.8M | -37.6M |
| Per Share Data | ||||||
| EPS (diluted) | $-0.56 | $-0.94 | $-0.64 | $-1.06 | $-1.07 | $-1.11 |
| Shares Outstanding (dil.) | 60M | 59M | 59M | 58M | 54M | 34M |
Aldeyra Therapeutics Inc. Income Statement — FAQ
Aldeyra Therapeutics Inc. (ALDX) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALDX's income statement history?
The chart and table above show Aldeyra Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.